Natural Biocon Complete Financial Statements
In FY2026, Natural Biocon (NATURAL) reported revenue ₹3 Cr, net profit ₹0 Cr and EPS ₹-0.02. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore NATURAL fundamental worth to estimate fundamental worth using multiple valuation models.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
NATURAL Revenue, Net Profit & EBITDA — Year-on-Year Growth
NATURAL YoY (March 2025 vs March 2026) — revenue -62.5%, expenses -62.5%. Review NATURAL earnings multiple to evaluate earnings-based valuation against sector peers.
NATURAL Income Statement — Revenue, EBITDA & Net Profit
Natural Biocon revenue ₹3 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹-0.02 (2026). For live price, earnings ratios and company overview, see Natural Biocon share price screener.
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 8 | 14 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
| Expenses | 3 | 8 | 13 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Operating Profit Margin % | -1.00% | 1.00% | 2.00% | 20.00% | 18.00% | 3.00% | 0.00% | 25.00% | 96.00% | 71.00% | -1.00% | -4.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Earnings Per Share (₹) | -0.02 | 0.02 | 0.13 | 0.16 | 0.01 | 0.00 | -0.07 | 0.06 | 0.62 | 0.01 | 0.00 | 0.00 |
NATURAL Balance Sheet — Assets, Liabilities & Shareholders' Equity
NATURAL total assets ₹37 Cr, total equity ₹31 Cr, total liabilities ₹ Cr (2026).
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 37 | 39 | 17 | 14 | 12 | 12 | 13 | 13 | 13 | 12 | 11 | 11 |
| Current Assets | 5 | 7 | 6 | 2 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
| Fixed Assets | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Investments | 0 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 14 | 14 | 10 | 9 | 9 | 9 | 10 | 9 | 8 | 8 | 8 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 31 | 32 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 11 | 11 | 11 |
| Share Capital | 26 | 26 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves & Surplus | 5 | 6 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
NATURAL Cash Flow Statement — Operating, Investing & Financing
Natural Biocon operating cash flow ₹1 Cr, investing ₹-21 Cr, financing ₹20 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 |
| Investing Activities | -21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 20 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |